title: Testosterone regulation of Alzheimer-like neuropathology in male 3xTg-AD mice involves both estrogen and androgen pathways.
abstract: Normal, age-related depletion of the androgen testosterone is a risk factor for Alzheimer's disease (AD) in men. Previously, we reported that experimental androgen depletion significantly accelerates development of AD-like neuropathology in the 3xTg-AD triple-transgenic mouse model of AD, an effect prevented by androgen treatment. Because testosterone is metabolized in brain into both the androgen dihydrotestosterone (DHT) and the estrogen 17β-estradiol (E2), testosterone can mediate its effects through androgen and or estrogen pathways. To define the role of androgen and estrogen pathways in regulation of AD-like neuropathology, we compared the effects of testosterone (T) and its metabolites DHT and E2 in male 3xTg-AD mice depleted of endogenous sex steroid hormones by gonadectomy (GDX). Male 3xTg-AD mice were sham GDX or GDX, immediately treated with vehicle, T, DHT, or E2, and 4 months later evaluated for two indices of AD-like neuropathology, β-amyloid (Aβ) accumulation and tau hyperphosphorylation. In comparison to sham GDX mice, we observed a significant increase in Aβ accumulation in GDX mice in subiculum, hippocampus, and amygdala. Treatment of GDX mice with T prevented the increased Aβ accumulation in all three brain regions. DHT treatment yielded similar results, significantly reducing Aβ accumulation across brain regions. Interestingly, E2 prevented Aβ accumulation in hippocampus but exerted only partial effects in subiculum and amygdala. Levels of tau hyperphosphorylation in sham GDX male 3xTg-AD mice were modest and only slightly increased by GDX. Treatment of GDX mice with T or E2 but not DHT reduced tau hyperphosphorylation to levels lower than observed in sham animals. These data suggest that testosterone regulates Aβ pathology through androgen and estrogen pathways and reduces tau pathology largely through estrogen pathways. These findings further define hormone pathways involved in regulation of AD-related pathology, information that is important for understanding disease etiology and developing pathway-specific hormone interventions.
authors.affiliation: Neuroscience Graduate Program, Davis School of Gerontology, University of Southern California, Los Angeles, CA 90089, USA.
authors.forename: Emily R
authors.initials: ER
authors.lastname: Rosario
authors.forename: Jenna
authors.initials: J
authors.lastname: Carroll
authors.forename: Christian J
authors.initials: CJ
authors.lastname: Pike
mesh_terms: D000544:Alzheimer Disease / Q000378:metabolism* / Q000473:pathology; D016229:Amyloid beta-Peptides / Q000378:metabolism; D000818:Animals; D001921:Brain / Q000378:metabolism* / Q000473:pathology; D013196:Dihydrotestosterone / Q000378:metabolism* / Q000494:pharmacology; D004195:Disease Models, Animal; D004958:Estradiol / Q000378:metabolism* / Q000494:pharmacology; D007150:Immunohistochemistry; D008297:Male; D051379:Mice; D008822:Mice, Transgenic; D010766:Phosphorylation; D015398:Signal Transduction / Q000502:physiology; D013739:Testosterone / Q000378:metabolism* / Q000494:pharmacology; D016875:tau Proteins / Q000378:metabolism
chemical_list: D016229:Amyloid beta-Peptides; D016875:tau Proteins; D013196:Dihydrotestosterone; D013739:Testosterone; D004958:Estradiol
references.citation: Neurobiol Aging. 2003 Dec;24(8):1063-70
references.pmid: 14643377
references.citation: Neuroscience. 2003;122(3):573-8
references.pmid: 14622899
references.citation: J Clin Endocrinol Metab. 2007 Mar;92(3):1049-57
references.pmid: 17164307
references.citation: Front Neuroendocrinol. 1998 Oct;19(4):323-62
references.pmid: 9799588
references.citation: JAMA. 2004 Sep 22;292(12):1431-2
references.pmid: 15383512
references.citation: J Neurosci. 2006 Dec 20;26(51):13384-9
references.pmid: 17182789
references.citation: Methods Mol Biol. 2003;222:211-22
references.pmid: 12710689
references.citation: J Alzheimers Dis. 2003 Aug;5(4):267-9
references.pmid: 14624021
references.citation: Proc Natl Acad Sci U S A. 2002 Oct 15;99(21):13589-94
references.pmid: 12370428
references.citation: Horm Behav. 2008 May;53(5):693-705
references.pmid: 18222446
references.citation: J Neurosci. 2007 Nov 28;27(48):13357-65
references.pmid: 18045930
references.citation: Ann Neurol. 1986 May;19(5):415-24
references.pmid: 3717905
references.citation: Am J Pathol. 2007 May;170(5):1669-75
references.pmid: 17456772
references.citation: Endocr Rev. 2005 Oct;26(6):833-76
references.pmid: 15901667
references.citation: J Neuroendocrinol. 2004 Feb;16(2):93-4
references.pmid: 14763993
references.citation: Neurobiol Aging. 2002 Mar-Apr;23(2):161-70
references.pmid: 11804699
references.citation: Neurology. 2005 Jun 28;64(12):2063-8
references.pmid: 15985573
references.citation: J Cereb Blood Flow Metab. 2009 Aug;29(8):1359-72
references.pmid: 19458604
references.citation: Pharmacol Rev. 2000 Dec;52(4):513-56
references.pmid: 11121509
references.citation: J Clin Endocrinol Metab. 2006 Jun;91(6):1995-2010
references.pmid: 16720669
references.citation: J Neurochem. 2003 Nov;87(4):1052-5
references.pmid: 14622134
references.citation: Horm Behav. 2008 May;53(5):741-52
references.pmid: 18067894
references.citation: J Neuroendocrinol. 2000 Apr;12(4):351-4
references.pmid: 10718932
references.citation: Proc Natl Acad Sci U S A. 2000 Feb 1;97(3):1202-5
references.pmid: 10655508
references.citation: Brain Res Rev. 2008 Mar;57(2):444-53
references.pmid: 17658612
references.citation: J Neurochem. 2008 Jun 1;105(6):2477-88
references.pmid: 18346198
references.citation: Scand J Clin Lab Invest. 2008;68(8):814-22
references.pmid: 18821130
references.citation: Proc Natl Acad Sci U S A. 2002 Feb 5;99(3):1140-5
references.pmid: 11805297
references.citation: Exp Neurol. 2003 Jun;181(2):301-12
references.pmid: 12782002
references.citation: Neuroscience. 2006;138(3):929-38
references.pmid: 16310316
references.citation: Ann N Y Acad Sci. 2005 Dec;1055:80-92
references.pmid: 16387720
references.citation: Psychoneuroendocrinology. 2004 Sep;29(8):1019-27
references.pmid: 15219653
references.citation: J Neurosci. 2004 Jan 14;24(2):495-9
references.pmid: 14724248
references.citation: Neurobiol Aging. 2011 Nov;32(11):1949-63
references.pmid: 20053478
references.citation: J Alzheimers Dis. 2008 Sep;15(1):129-37
references.pmid: 18780973
references.citation: Endocrinology. 1995 Aug;136(8):3213-21
references.pmid: 7628354
references.citation: J Neurosci. 1994 Dec;14(12):7680-7
references.pmid: 7996203
references.citation: Proc Natl Acad Sci U S A. 2001 May 22;98(11):6330-5
references.pmid: 11371645
references.citation: Horm Behav. 2008 May;53(5):706-15
references.pmid: 18395206
references.citation: J Neurosci. 1992 Jul;12(7):2549-54
references.pmid: 1613547
references.citation: J Steroid Biochem Mol Biol. 1993 Feb;44(2):105-12
references.pmid: 8439515
references.citation: Behav Neurosci. 2004 Dec;118(6):1352-64
references.pmid: 15598144
references.citation: Learn Mem. 2009 Jul 24;16(8):479-85
references.pmid: 19633137
references.citation: JAMA. 2001 May 2;285(17):2195-6
references.pmid: 11325319
references.citation: J Neuroendocrinol. 2009 Mar;21(4):351-8
references.pmid: 19207807
references.citation: Endocrine. 2005 Apr;26(3):317-26
references.pmid: 16034187
references.citation: J Neurosci. 2005 Sep 28;25(39):8843-53
references.pmid: 16192374
references.citation: Neuroscience. 2006;138(3):1015-20
references.pmid: 16310318
references.citation: JAMA. 1989 Nov 10;262(18):2551-6
references.pmid: 2810583
references.citation: Endocrinology. 1976 Apr;98(4):864-74
references.pmid: 179788
references.citation: Brain Res. 2005 Sep 14;1056(1):22-35
references.pmid: 16122717
references.citation: J Neurosci. 2008 Aug 20;28(34):8430-41
references.pmid: 18716201
references.citation: J Comp Neurol. 1997 Dec 1;388(4):507-25
references.pmid: 9388012
references.citation: Ann N Y Acad Sci. 2005 Jun;1052:210-24
references.pmid: 16024764
references.citation: J Steroid Biochem. 1986 Mar;24(3):703-8
references.pmid: 3702447
references.citation: Endocrinology. 2005 Jan;146(1):147-55
references.pmid: 15471969
references.citation: J Biol Chem. 2006 Dec 22;281(51):39413-23
references.pmid: 17056594
references.citation: J Neurochem. 1999 Apr;72(4):1552-63
references.pmid: 10098861
references.citation: Front Neuroendocrinol. 2009 Jul;30(2):239-58
references.pmid: 19427328
references.citation: J Androl. 2003 Jul-Aug;24(4):568-76
references.pmid: 12826696
references.citation: Trends Neurosci. 1997 Apr;20(4):154-9
references.pmid: 9106355
references.citation: Endocrinology. 2008 May;149(5):2607-11
references.pmid: 18276750
references.citation: J Neurosci. 2003 Mar 1;23(5):1588-92
references.pmid: 12629162
references.citation: Proc Natl Acad Sci U S A. 1997 Jun 24;94(13):6612-7
references.pmid: 9192613
references.citation: Neurobiol Aging. 2011 Apr;32(4):604-13
references.pmid: 19428144
references.citation: Neurochem Res. 2008 Sep;33(9):1811-20
references.pmid: 18338250
references.citation: Acta Psychiatr Scand. 1987 Nov;76(5):465-79
references.pmid: 3324647
references.citation: Neuron. 2003 Jul 31;39(3):409-21
references.pmid: 12895417
references.citation: J Neurosci. 2006 Feb 1;26(5):1448-56
references.pmid: 16452668
references.citation: J Comp Neurol. 1990 Apr 1;294(1):76-95
references.pmid: 2324335
references.citation: Brain Res. 2001 Nov 16;919(1):160-5
references.pmid: 11689174
references.citation: Trends Cogn Sci. 2006 Feb;10(2):77-82
references.pmid: 16386941
references.citation: Neurosci Lett. 2000 Dec 15;296(1):49-52
references.pmid: 11099831